Speciociliatine

ID: ALA4546925

Cas Number: 14382-79-7

PubChem CID: 15560576

Product Number: S353356, Order Now?

Max Phase: Preclinical

Molecular Formula: C23H30N2O4

Molecular Weight: 398.50

Molecule Type: Unknown

Associated Items:

This product is currently unavailable

Names and Identifiers

Canonical SMILES:  CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@H]2C[C@@H]1/C(=C\OC)C(=O)OC

Standard InChI:  InChI=1S/C23H30N2O4/c1-5-14-12-25-10-9-15-21-18(7-6-8-20(21)28-3)24-22(15)19(25)11-16(14)17(13-27-2)23(26)29-4/h6-8,13-14,16,19,24H,5,9-12H2,1-4H3/b17-13+/t14-,16+,19-/m1/s1

Standard InChI Key:  LELBFTMXCIIKKX-MYLQJJOTSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   17.1197  -11.6553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6988  -10.9454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5750  -12.2785    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.5878  -13.0586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9411  -11.6512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3414  -10.9330    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.1751  -12.3528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8898  -11.1311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8155  -11.9525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3538  -12.3528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1751  -13.7726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1627  -10.9206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5837  -11.6388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0991  -10.2314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9287  -10.2231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4091  -13.0586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5961  -14.4742    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.3620  -13.7726    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.8177  -12.3487    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2253  -10.6606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0685  -12.2909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3968  -11.6305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9576  -14.4783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6391  -12.3487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8012  -10.9165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4824  -10.9949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4040  -11.8163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6439  -12.4147    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   15.3042   -9.8473    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.6392   -9.3723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  7  4  1  1
  5  1  1  0
  6  5  1  0
  7 10  1  0
  8  2  1  0
  9  3  1  0
 10  5  1  0
 11  4  1  0
 12  6  1  0
 13  7  1  0
 14  2  1  0
 15  6  1  0
 16  4  2  0
 17 11  2  0
 18 11  1  0
 19 16  1  0
 20  8  2  0
 21  9  2  0
 13 22  1  1
 23 18  1  0
 24 19  1  0
 25 22  1  0
 26 20  1  0
 27 21  1  0
  5 28  1  1
  8  9  1  0
 15 14  1  0
 12 13  1  0
 26 27  2  0
 20 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4546925

    Speciociliatine

Associated Targets(Human)

OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2B Tclin Alpha-2b adrenergic receptor (4412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRL1 Tchem Nociceptin receptor (3823 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr1b Serotonin 1b (5-HT1b) receptor (2343 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprm1 Mu opioid receptor (1674 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprk1 Kappa opioid receptor (991 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprd1 Delta opioid receptor (3127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 398.50Molecular Weight (Monoisotopic): 398.2206AlogP: 3.83#Rotatable Bonds: 5
Polar Surface Area: 63.79Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.04CX LogP: 3.30CX LogD: 3.14
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.47Np Likeness Score: 1.54

References

1. Obeng S, Kamble SH, Reeves ME, Restrepo LF, Patel A, Behnke M, Chear NJ, Ramanathan S, Sharma A, León F, Hiranita T, Avery BA, McMahon LR, McCurdy CR..  (2020)  Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected Indole-Based Kratom Alkaloids.,  63  (1): [PMID:31834797] [10.1021/acs.jmedchem.9b01465]
2. Chear NJ, León F, Sharma A, Kanumuri SRR, Zwolinski G, Abboud KA, Singh D, Restrepo LF, Patel A, Hiranita T, Ramanathan S, Hampson AJ, McMahon LR, McCurdy CR..  (2021)  Exploring the Chemistry of Alkaloids from Malaysian Mitragyna speciosa (Kratom) and the Role of Oxindoles on Human Opioid Receptors.,  84  (4.0): [PMID:33635670] [10.1021/acs.jnatprod.0c01055]
3. Kamble SH, Berthold EC, King TI, Raju Kanumuri SR, Popa R, Herting JR, León F, Sharma A, McMahon LR, Avery BA, McCurdy CR..  (2021)  Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats.,  84  (4.0): [PMID:33620222] [10.1021/acs.jnatprod.0c01163]
4. León F, Obeng S, Mottinelli M, Chen Y, King TI, Berthold EC, Kamble SH, Restrepo LF, Patel A, Gamez-Jimenez LR, Lopera-Londoño C, Hiranita T, Sharma A, Hampson AJ, Canal CE, McMahon LR, McCurdy CR..  (2021)  Activity of Mitragyna speciosa ("Kratom") Alkaloids at Serotonin Receptors.,  64  (18.0): [PMID:34467758] [10.1021/acs.jmedchem.1c00726]
5. Smith MT, Kong D, Kuo A, Imam MZ, Williams CM..  (2022)  Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources.,  65  (3.0): [PMID:34995453] [10.1021/acs.jmedchem.0c01915]
6. Chakraborty S, Uprety R, Slocum ST, Irie T, Le Rouzic V, Li X, Wilson LL, Scouller B, Alder AF, Kruegel AC, Ansonoff M, Varadi A, Eans SO, Hunkele A, Allaoa A, Kalra S, Xu J, Pan YX, Pintar J, Kivell BM, Pasternak GW, Cameron MD, McLaughlin JP, Sames D, Majumdar S..  (2021)  Oxidative Metabolism as a Modulator of Kratom's Biological Actions.,  64  (22.0): [PMID:34783240] [10.1021/acs.jmedchem.1c01111]

Source